Management of colorectal carcinoma in children and young adults

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue SUPPL. 2, 2012, Pages

  Goldberg, John ^a   Furman, Wayne L ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

children; Colorectal carcinoma; management guidelines; young adults

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PANITUMUMAB;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ANEMIA; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CHILD; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; YOUNG ADULT;

EID: 84860302029     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31824e38c1     Document Type: Review

References (49)

1. American Cancer Society. Cancer Facts and Figures, 2010. Atlanta, GA: American Cancer Society; 2011.
2. Pappo AS, Rodriguez-Galindo C, Furman WL. Management of infrequent cancers of childhood. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Vol 6th. Phila-delphia, PA: Lippincott Williams & Wilkins; 2011:1098-1123.
3. Hill DA, Furman WL, Billups CA, et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol. 2007;25:5808-5814.
4. Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Paediatr Drugs. 2008;10:177-192. (Pubitemid 351629673)
5. Spunt S, Furman WL, La Quaglia MP, et al. Colon and rectal cancer. In: Bleyer A, O'Leary M, Ries L, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006:123-133.
6. Donohoe CL, Pidgeon GP, Lysaght J, et al. Obesity and gastrointestinal cancer. Br JSurg. 2010;97:628-642.
7. Libutti SK, Saltz LB, Rustgi AK, et al. Cancer of the colon. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles & Practice of Oncology. Vol 7th. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1061-1109.
8. Datta RV, Laquaglia MP, Paty PB. Genetic and phenotypic correlates ofcolorectal cancer in young patients. N Engl J Med. 2000;342:137-138. (Pubitemid 30036612)
9. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003;124:1574-1594. (Pubitemid 36617678)
10. Andersson A, Bergdahl L. Carcinoma of the colon in children: a report of six new cases and a review of the literature. J Pediatr Surg. 1976;11:967-971. (Pubitemid 8013684)
11. Chantada GL, Perelli VB, Lombardi MG, et al. Colorectal carcinoma in children, adolescents, and young adults. JPediatr Hematol Oncol. 2005;27:39-41. (Pubitemid 40175960)
12. Durno C, Aronson M, Bapat B, et al. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut. 2005;54:1146-1150. (Pubitemid 41025910)
13. Durno CA, Gallinger S. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. J Pediatr Gastro-enterol Nutr. 2006;43:5-15. (Pubitemid 44022380)
14. Ferrari A, Rognone A, Casanova M, et al. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr Blood Cancer. 2008;50:588-593. (Pubitemid 351155830)
15. Karnak I, Ciftci AO, Senocak ME, et al. Colorectal carcinoma in children. JPediatr Surg. 1999;34:1499-1504. (Pubitemid 29503809)
16. Laquaglia MP, Heller G, Filippa DA, et al. Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. JPediatr Surg. 1992;27:1085-1089.
17. Middelkamp JN, Haffner H. Carcinoma of the colon in children. Pediatrics. 1963;32:558-571.
18. Radhakrishnan CN, Bruce J. Colorectal cancers in children without any predisposing factors. A report of eight cases and review of the literature. Eur JPediatr Surg. 2003;13:66-68. (Pubitemid 36841062)
19. Sharma AK, Gupta CR. Colorectal cancer in children: case report and review ofliterature. Trop Gastroenterol. 2001;22:36-39.
20. Taguchi T, Suita S, Hirata Y, et al. Carcinoma of the colon in children: a case report and review of 41 Japanese cases. JPediatr Gastroenterol Nutr. 1991;12:394-399.
21. Alkhouri N, Franciosi JP, Mamula P. Familial adenomatous polyposis in children and adolescents. J Pediatr Gastroenterol Nutr. 2010;51:727-732.
22. Corredor J, Wambach J, Barnard J. Gastrointestinal polyps in children: advances in molecular genetics, diagnosis, and management. JPediatr. 2001;138:621-628. (Pubitemid 32417659)
23. Distante S, Nasioulas S, Somers GR, et al. Familial adenom-atous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. JMedGenet. 1996;33:157-160. (Pubitemid 26055748)
24. Markowitz SD, Bertagnolli MM. Molecular origins ofcancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-2460.
25. Pratt CB, Rao BN, Merchant TE, et al. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/ interferon-alpha 2a and radiation therapy. Med Pediatr Oncol. 1999;32:459-460. (Pubitemid 29249753)
26. Consorti F, Lorenzotti A, Midiri G, et al. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol. 2000;73:70-74. (Pubitemid 30123728)
27. Berger KL, Nicholson SA, Dehdashti F, et al. FDG PET evalua-tion of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Am J Roentgenol. 2000;174:1005-1008. (Pubitemid 30179992)
28. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 2005;23:338-351. (Pubitemid 41656973)
29. Rao BN, Pratt CB, Fleming ID, et al. Colon carcinoma in children and adolescents. A review of 30 cases. Cancer. 1985; 55:1322-1326. (Pubitemid 15143410)
30. Angel CA, Pratt CB, Rao BN, et al. Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents. Cancer. 1992;69:1487-1491.
31. American Joint Committee on Cancer Staging Handbook. In: Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. Vol 7th. Springer: American Joint Committee on Cancer; 2010.
32. Rodriguez-Bigas MA, Hoff PM, Crane CH. Carcinoma of the colon and rectum. In: KuffDW, Bast RC Jr, Hait WN, et al, eds. Cancer Medicine 7. London: BC Decker Inc.; 2006:1369-1391.
33. Gunderson LL, Jessup JM, Sargent DJ, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264-271.
34. Benson AB III, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-3419. (Pubitemid 41103700)
35. Figueredo A, Charette ML, Maroun J, et al. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol. 2004;22:3395-3407. (Pubitemid 41103699)
36. Saltz LB. Adjuvant therapy for colon cancer. Surg Oncol Clin N Am. 2010;19:819-827.
37. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-2351. (Pubitemid 38702845)
38. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109-3116.
39. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22:229-237. (Pubitemid 41095086)
40. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342. (Pubitemid 38702844)
41. Hurwitz HI, Yi J, Ince W, et al. The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer. Oncologist. 2009;14:22-28.
42. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337-345. (Pubitemid 38944402)
43. Addeo R, Caraglia M, Cerbone D, et al. Panitumumab: a new frontier of target therapy for the treatment of metastatic colorectal cancer. Expert Rev Anticancer Ther. 2010;10:499-505.
44. Giusti RM, Shastri KA, Cohen MH, et al. Drug approval summary: panitumumab (Vectibix). Oncologist. 2007;12:577-583. (Pubitemid 350012121)
45. Van CE, Peeters M, Siena S, et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol. 2007;25:1658-1664. (Pubitemid 46797944)
46. VanderMeer TJ, Callery MP, Meyers WC. The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma. Hematol Oncol Clin North Am. 1997;11:759-777. (Pubitemid 27327299)
47. Desch CE, Benson AB III, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clini-cal Oncology practice guideline. J Clin Oncol. 2005;23:8512-8519.
48. Negri FV, Wotherspoon A, Cunningham D, et al. Mucinous histology predicts for reduced fluorouracil responsiveness and sur-vival in advanced colorectal cancer. Ann Oncol. 2005;16:1305-1310. (Pubitemid 41158475)
49. Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375:1030-1047.